We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing.
- Authors
Eyre, David W.; Fawley, Warren N.; Rajgopal, Anu; Settle, Christopher; Mortimer, Kalani; Goldenberg, Simon D.; Dawson, Susan; Crook, Derrick W.; Peto, Tim E. A.; Walker, A. Sarah; Wilcox, Mark H.
- Abstract
Background. Variation in Clostridium difficile infection (CDI) rates between healthcare institutions suggests overall incidence could be reduced if the lowest rates could be achieved more widely. Methods. We used whole-genome sequencing (WGS) of consecutive C. difficile isolates from 6 English hospitals over 1 year (2013–14) to compare infection control performance. Fecal samples with a positive initial screen for C. difficile were sequenced. Within each hospital, we estimated the proportion of cases plausibly acquired from previous cases. Results. Overall, 851/971 (87.6%) sequenced samples contained toxin genes, and 451 (46.4%) were fecal-toxin-positive. Of 652 potentially toxigenic isolates >90-days after the study started, 128 (20%, 95% confidence interval [CI] 17–23%) were genetically linked (within ≤2 single nucleotide polymorphisms) to a prior patient’s isolate from the previous 90 days. Hospital 2 had the fewest linked isolates, 7/105 (7%, 3–13%), hospital 1, 9/70 (13%, 6–23%), and hospitals 3–6 had similar proportions of linked isolates (22– 26%) (P ≤ .002 comparing hospital-2 vs 3–6). Results were similar adjusting for locally circulating ribotypes. Adjusting for hospital, ribotype-027 had the highest proportion of linked isolates (57%, 95% CI 29–81%). Fecal-toxin-positive and toxin-negative patients were similarly likely to be a potential transmission donor, OR = 1.01 (0.68–1.49). There was no association between the estimated proportion of linked cases and testing rates. Conclusions. WGS can be used as a novel surveillance tool to identify varying rates of C. difficile transmission between institutions and therefore to allow targeted efforts to reduce CDI incidence.
- Subjects
CLOSTRIDIOIDES difficile; NUCLEOTIDE sequencing; HOSPITALS; TREATMENT effectiveness; PATIENTS; THERAPEUTICS
- Publication
Clinical Infectious Diseases, 2017, Vol 65, Issue 3, p433
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/cix338